Vaccination against Haemophilus influenzae type b in the Russian Federation and Abroad
https://doi.org/10.31631/2073-3046-2016-15-1-61-66
Abstract
Vaccination against Haemophilus influenzae type b infection is the principal method of its prophylaxis. This position is supported the results of extensive immunization which leading to significant morbidity decrease. The article discusses compositions of modern conjugated mono and associated vaccines, which has been licenced in Russia, USA, Great Britain, Canada and Australia, tactics and schedules of immunization. The special attention gives to immunocompromised person s vaccination, who possess the high sensibility to the infection.
About the Authors
N. A. Ozeretskovsky
Federal State Budgeteve Institution «Scientific Centre for Expertise of Medical Products» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
T. I. Nemirovskaya
Federal State Budgeteve Institution «Scientific Centre for Expertise of Medical Products» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Haemophilus influenzae type b ( Hib) Vaccination Position Paper – July 2013. WHO. Weekly epidemiological record; 38: 413 – 428.
2. Prevention and Control of Haemophilus influenzae Type b Disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR; Feb.28, 2014; 63 (1).
3. Haemophilus influenzae type b immunization. Bulletins du Centre International de Lʹ Enfance; 1992: 33 – 34.
4. Haemophilus influenzae type b ( Hib). The Green Book. Immunization against infections desease. 2013; 2 (16): 127 – 143.
5. Interaction between Federal Service of Surveillance on Consumer’ Rights Protection and Human Wellbeing (Rospotrebnadzor) territory organs and institutions with Reference Centre for monitoring of bacterial meningitis. Rospotrebnadzor business letter. June 29, 2010. № 01/96-20-0-32 (in Russia).
6. Dajani A, Asmar B,Thirumoorthi M. Systemic Haemophilus influenzae disease: an over - view. J. Pediatris 1979; 94 (3): 355 – 364.
7. Chandrasekar P.H. Haemophilus meningitis. Available at: http://misc.medscape.com/pi/phone/medscapeapp/html/A1164916-business.html.
8. Epidemiology and prevention of vaccine - preventable diseases. The Pink Book: Course textbook – 12th Ed. Second Printing (May 2012). Available at: http://www.cdc.gov/vaccines/pubs/pinkbook/hib.html
9. Recommendation of the standing committee on vaccination (STIKO) at the Robert Koch Institute epidemiologisches bulletin, 25 aug.,2014; 34: 305 – 340.
10. Briere E. C., Rubin L., Moro P. L., Colin A., Messonnier N. Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP). MMWR, Feb. 28, 2014 ; 63 (RR01): 1 – 14.
11. Canadian Immunization Guide. Part 4. Active Vaccines. Haemophilus influenzae type b Vaccine. 2014. Available at: http://www.phac-aspc.gс.ca/publicat/cig-gci/p04-hea-eng.php
12. Groups with special vaccination requirements. The Australian immunization Handbook 10th, 2013. Available at: http://www.immunise.health.gov.au/internet/immunize/publishing.nsf
13. UNICEF.WHO. A statistical reference containing data through 2013. Immunization summary. The 2014 Edition.
14. Haemophilus influenzae infection. Red Book. 29 Edition; American Academy of Pediatrics; 2012: 345 – 352.
15. Summary of notifiable diseases United States, 2012. MMWR. Sept 19, 2014; 61 (53): 25.
16. Notifiable diseases and neonatality tables. Summary of notifiable diseases. MMWR. Jan. 16. 2015; 64 (01): ND-1-ND-19.
17. WHO vaccine-preventable diseases: monitoring system.2014.Global summary. Available at: http:// http://www.//apps.WHO.int/immunization monitoring/global summary/time series.
18. Global routine vaccination coverage, 2013.Weekly epidemiological record. 21 Nov., 2014; 47 (89): 517 – 528.
19. Global immunization data. WHO. UNICEF. July. 2014. Available at: http://www.who.int/immunization/monitoring surveillance/global immunization data.pdf
20. National immunization schedule. Rossiiskaya Gazeta (Russian newspaper) № 6381, 2014, May.16 (in Russia).
21. Haemophilus influenzae type b infection. Epidemiolology and vaccinoprophylactis. Methodological recommendation. № 3.3.1.0001-10 (in Russia).
22. WHO information Sheet observed rate of vaccine Haemophilus influenzae type b (Hib) vaccine. April 2012. Available at: http:// www.who.int/vaccine Hib safety/initiative/tools/ Hib Vaccine - rates – information – sheet.pdf
23. Haemophilus b conjugated vaccines for prevention of Haemophilus influenzae type b disease among infants and children. Recommendations of ACIP. MMWR, Jan.11; 1991; 40 (RRI): 1 – 7.
24. Bohle K., Davis R., Marcy S. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics, 2003, oct., 112 (4): 815 – 820.
25. Moro P.L., Jankosky C., Mensehik D. Adverse Events follow Haemophilus influenzae type b vaccine in the vaccine adverse reporting system 1990 – 2013. The Journal of Pediatrics. Jan.2015; 166 (4): 992 – 997.
26. The contraindications for immunization vaccines of national schedula. Methodological Indications. М I 3.3.1.1095-02 (in Russia).
27. Rubin L.G., Levin M.J., Davies E.G., Tomblyn M.,Bousvaros A., at all. 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host. IDSA Guidelines. Clin.Inf. Dis., 2014; 58 (3): 44 – 87.
Review
For citations:
Ozeretskovsky N.A., Nemirovskaya T.I. Vaccination against Haemophilus influenzae type b in the Russian Federation and Abroad. Epidemiology and Vaccinal Prevention. 2016;15(1):61-66. (In Russ.) https://doi.org/10.31631/2073-3046-2016-15-1-61-66
Views:
1077
Email this article 